Amphastar Pharma Files 2024 Proxy Statement

Ticker: AMPH · Form: DEF 14A · Filed: 2025-04-14T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, executive-compensation, sec-filing

TL;DR

Amphastar's proxy statement is out, detailing exec pay and equity awards for 2024.

AI Summary

Amphastar Pharmaceuticals, Inc. filed its DEF 14A on April 14, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity awards granted to PEO and Non-PEO NEO members. Specific values for equity awards granted in the current year and adjustments to the fair value of prior year awards are presented for the fiscal year 2024.

Why It Matters

This filing provides transparency into how Amphastar Pharmaceuticals compensates its top executives, which can influence investor decisions and perceptions of corporate governance.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that provides information on executive compensation and does not indicate any immediate operational or financial risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing detailed information on matters to be voted upon, including executive compensation, director elections, and other corporate governance issues.

Who are the key individuals whose compensation is detailed in this filing?

The filing details compensation for PEO (Principal Executive Officer) and Non-PEO NEO (Named Executive Officer) members, as indicated by the tags amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:PeoMember and amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:NonPeoNeoMember.

What specific types of equity awards are discussed in the filing?

The filing discusses 'Equity Awards Value in Compensation Table' and 'Equity Awards Adjustments Year-End Fair Value of Awards Granted in Current Year' for both PEO and Non-PEO NEO members.

What is the fiscal year end for Amphastar Pharmaceuticals, Inc.?

Amphastar Pharmaceuticals, Inc.'s fiscal year ends on December 31 (1231).

When is the period of report for this DEF 14A filing?

The conformed period of report for this DEF 14A filing is 20250602.

From the Filing

0001297184-25-000018.txt : 20250414 0001297184-25-000018.hdr.sgml : 20250414 20250414160717 ACCESSION NUMBER: 0001297184-25-000018 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250602 FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 330702205 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 25836098 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 DEF 14A 1 amph-20250602xdef14a.htm DEF 14A AMPHASTAR PHARMACEUTICALS, INC. DEF 14A 0001297184 false 0001297184 3 2024-01-01 2024-12-31 0001297184 2 2024-01-01 2024-12-31 0001297184 1 2024-01-01 2024-12-31 0001297184 2023-01-01 2023-12-31 0001297184 2022-01-01 2022-12-31 0001297184 2021-01-01 2021-12-31 0001297184 2020-01-01 2020-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:PeoMember 2022-01-01 2022-12-31 0001297184 amph:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2022-01-01 2022-12-31 0001297184 amph:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001297184 amph:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstanding

View on Read The Filing